Brought to you by 
AlgoRx withdraws filing for $51mm IPO
11 Oct 2005
Executive Summary
Citing poor market conditions, AlgoRx Pharmaceuticals Inc. (pain management therapeutics) has postponed its initial public offering in which it had hoped to sell 6.8mm common shares priced between $7 and $8 per share.
Deal Industry
- Biotechnology
- Pharmaceuticals
-
Pharmaceuticals
-
Drug Delivery
- Site Specific
- Transdermal
-
Drug Delivery
Deal Status
- Withdrawn
Deal Type
-
Financing
- IPO
Already a Biomedtracker subscriber?
You have access to the full deal record through your subscription
Want to become a subscriber?
Subscribers get more deal details, updates, deal financials and deal products.
Questions?
Questions?
Please contact Sales at: (212) 520-2765 or email [email protected]
Related Companies
You must sign in to use this functionality
Authentication.SignIn.HeadSignInHeader
AlgoRx withdraws filing for $51mm IPO
Email Deal
All set! This article has been sent to my@email.address.
All fields are required. For multiple recipients, separate email addresses with a semicolon.
DCD.EmailPopout.Notice